Refreshing results…
Relapse Timing Is Associated With Distinct Evolutionary Dynamics in Diffuse Large B-Cell Lymphoma
Download from doi.orgNivolumab combined with brentuximab vedotin for relapsed/refractory mediastinal gray zone lymphoma
Download from ashpublications.orgGenomic profiling for clinical decision making in lymphoid neoplasms
UploadMutational landscape of gray zone lymphoma
UploadFive-Year Outcomes With Nivolumab in Patients With Wild-Type BRAF Advanced Melanoma
Download from doi.orgMissing publications? Search for publications with a matching author name.